Efficacy and Safety of Belimumab in SLE Patients

Clinical trial NCT04515719 · COMPLETED

Trial details

NCT number: NCT04515719
Sponsor: RenJi Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2021-03-10
Primary completion: 2022-04-10
Enrollment: 231

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.